These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1122 related items for PubMed ID: 21205141

  • 1. New direct-acting antivirals' combination for the treatment of chronic hepatitis C.
    Asselah T, Marcellin P.
    Liver Int; 2011 Jan; 31 Suppl 1():68-77. PubMed ID: 21205141
    [Abstract] [Full Text] [Related]

  • 2. Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow.
    Asselah T, Marcellin P.
    Liver Int; 2012 Feb; 32 Suppl 1():88-102. PubMed ID: 22212578
    [Abstract] [Full Text] [Related]

  • 3. Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.
    Manns MP, Markova AA, Calle Serrano B, Cornberg M.
    Liver Int; 2012 Feb; 32 Suppl 1():27-31. PubMed ID: 22212568
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
    Michielsen P, Ho E, Francque S.
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
    [Abstract] [Full Text] [Related]

  • 8. Impact of HCV protease-inhibitor-based triple therapy for chronic HCV genotype 1 infection.
    Ferenci P, Reddy KR.
    Antivir Ther; 2011 Mar; 16(8):1187-201. PubMed ID: 22155901
    [Abstract] [Full Text] [Related]

  • 9. Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.
    Wedemeyer H, Forns X, Hézode C, Lee SS, Scalori A, Voulgari A, Le Pogam S, Nájera I, Thommes JA.
    PLoS One; 2016 Mar; 11(1):e0145409. PubMed ID: 26752189
    [Abstract] [Full Text] [Related]

  • 10. Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.
    Bailly F, Pradat P, Virlogeux V, Zoulim F.
    Dig Dis; 2015 Mar; 33(4):613-23. PubMed ID: 26159282
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.
    Bailly F, Virlogeux V, Dufour C, Pradat P, Hézode C, Larrey D, Alric L, Samuel D, Bourlière M, Métivier S, Zarski JP, Fontaine H, Loustaud-Ratti V, Serfaty L, Bronowicki JP, Carrat F, Zoulim F, CUPIC Study Group.
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):443-50. PubMed ID: 25636238
    [Abstract] [Full Text] [Related]

  • 13. Interferon free therapy with direct acting antivirals for HCV.
    Asselah T, Marcellin P.
    Liver Int; 2013 Feb; 33 Suppl 1():93-104. PubMed ID: 23286852
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment failure with new hepatitis C drugs.
    Soriano V, Vispo E, Poveda E, Labarga P, Barreiro P.
    Expert Opin Pharmacother; 2012 Feb; 13(3):313-23. PubMed ID: 22242928
    [Abstract] [Full Text] [Related]

  • 17. Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevir.
    Hofmann WP, Chung TL, Osbahr C, Susser S, Karey U, Mihm U, Welsch C, Lötsch J, Sarrazin C, Zeuzem S, Herrmann E.
    Antivir Ther; 2011 Feb; 16(5):695-704. PubMed ID: 21817191
    [Abstract] [Full Text] [Related]

  • 18. Future perspectives: towards interferon-free regimens for HCV.
    Gane E.
    Antivir Ther; 2012 Feb; 17(6 Pt B):1201-10. PubMed ID: 23186654
    [Abstract] [Full Text] [Related]

  • 19. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V, Sansonno D, Russi S, Pavone F, Dammacco F.
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.